Rhythm Pharmaceuticals, Inc. RYTM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Rhythm Pharmaceuticals, Inc. (RYTM), dont 19 achats et 30 ventes. Le total des achats d'initiés s'élève à $3.32M et le total des ventes d'initiés à $2.23M.

Les initiés notables ayant une activité récente comprennent Popovits Kimberly J, Mazabraud Yann, Mathers Edward T. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — RYTM

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Popovits Kimberly J	Director	Inconnu	-	-	-	-
2026-04-01	Popovits Kimberly J	Director	Attribution de RSU	6,808	-	-	6,808
2026-04-01	Mazabraud Yann	EVP, Head of International	Exercice d'Options (Vente)	2,500	-	-	5,000
2026-03-12	Mathers Edward T	Director	Autre (Achat)	4,199	-	-	14,168
2026-03-04	German Christopher Paul	Corporate Controller & CAO	Vente Informative	5,614	$89.56	$502.79K	160
2026-03-02	Smith Hunter C	Chief Financial Officer	Exercice d'Options (Vente)	6,099	$6.80	$41.47K	91,401
2026-03-02	Mathers Edward T	Director	Autre (Achat)	4,198	-	-	9,969
2026-03-02	Mazabraud Yann	EVP, Head of International	Attribution de RSU	35,000	$94.94	$3.32M	35,000
2026-03-01	German Christopher Paul	Corporate Controller & CAO	Exercice d'Options (Vente)	1,162	-	-	1,162
2026-02-19	Smith Hunter C	Chief Financial Officer	Vente Informative	585	$103.28	$60.42K	110,512
2026-02-17	Smith Hunter C	Chief Financial Officer	Vente Informative	200	$103.84	$20.77K	114,897
2026-02-14	Mazabraud Yann	EVP, Head of International	Exercice d'Options (Vente)	10,000	-	-	30,000
2026-02-12	Smith Hunter C	Chief Financial Officer	Vente Informative	100	$100.10	$10.01K	118,466
2026-02-11	Smith Hunter C	Chief Financial Officer	Attribution de RSU	25,000	-	-	25,000
2026-02-11	German Christopher Paul	Corporate Controller & CAO	Attribution de RSU	5,215	-	-	5,215
2026-02-11	Meeker David P	President and CEO	Attribution de RSU	71,900	-	-	71,900
2026-02-11	Mazabraud Yann	EVP, Head of International	Attribution de RSU	23,350	-	-	23,350
2026-02-11	Lee Jennifer Kayden	EVP, Head of North America	Attribution de RSU	21,650	-	-	21,650
2026-02-11	Cramer Pamela J.	Chief Human Resources Officer	Attribution de RSU	11,650	-	-	11,650
2026-02-11	Shulman Joseph	Chief Technical Officer	Attribution de RSU	15,000	-	-	15,000
2026-02-11	Garfield Alastair	Chief Scientific Officer	Attribution de RSU	16,650	-	-	16,650
2026-02-10	Smith Hunter C	Chief Financial Officer	Vente Informative	100	$104.76	$10.48K	122,824
2026-02-05	Smith Hunter C	Chief Financial Officer	Vente Informative	3,381	$106.06	$358.6K	125,537
2026-02-04	Smith Hunter C	Chief Financial Officer	Vente Informative	747	$107.67	$80.43K	128,918
2026-02-01	German Christopher Paul	Corporate Controller & CAO	Retenue Fiscale RSU	1,138	$108.99	$124.03K	3,433
2026-02-01	Meeker David P	President and CEO	Exercice d'Options (Vente)	14,125	-	-	14,125
2026-02-01	Smith Hunter C	Chief Financial Officer	Exercice d'Options (Vente)	4,062	-	-	-
2026-02-01	Mazabraud Yann	EVP, Head of International	Exercice d'Options (Vente)	5,500	-	-	11,000
2026-02-01	Lee Jennifer Kayden	EVP, Head of North America	Exercice d'Options (Vente)	3,437	-	-	-
2026-02-01	Cramer Pamela J.	Chief Human Resources Officer	Exercice d'Options (Vente)	2,343	-	-	-
2026-02-01	Shulman Joseph	Chief Technical Officer	Exercice d'Options (Vente)	2,656	-	-	-
2026-02-01	Garfield Alastair	Chief Scientific Officer	Retenue Fiscale RSU	2,026	$108.99	$220.81K	7,763
2025-12-11	Cramer Pamela J.	Chief Human Resources Officer	Exercice d'Options (Vente)	3,350	$27.35	$91.62K	8,375
2025-11-20	Cramer Pamela J.	Chief Human Resources Officer	Exercice d'Options (Vente)	3,350	$27.35	$91.62K	11,725
2025-06-24	Mcgirr David W J	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Good Jennifer L	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Bedrosian Camille L	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Mathers Edward T	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Jean Christophe	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Arbuckle Stuart A	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-24	Tetrault Lynn A.	Director	Attribution de RSU	4,712	-	-	4,712
2025-06-18	Mcgirr David W J	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Good Jennifer L	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Bedrosian Camille L	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Mathers Edward T	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Jean Christophe	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Arbuckle Stuart A	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-18	Tetrault Lynn A.	Director	Exercice d'Options (Vente)	4,000	-	-	-
2025-06-10	German Christopher Paul	Corporate Controller & CAO	Vente Informative	2,069	$67.19	$139.02K	1,889
2025-06-06	Cramer Pamela J.	Chief Human Resources Officer	Vente Informative	7,031	$68.05	$478.43K	19,209

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration